Signature »

Janux Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Signature from 13F filings

Historical chart of Signature investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 2.0k 13.90
2025-12-31 $5.0k 360 13.80
2025-03-31 $243 9 27.00
2024-12-31 $1.6k 29 53.55

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
State Street Corporation
FMR
Vanguard Group
Prosight Management
OrbiMed Advisors
TCG Crossover Management
Wellington Management Company
Alyeska Investment Group
Citadel Advisors
Geode Capital Management
Goldman Sachs Group
Woodline Partners
Logos Global Management

View all funds holding Janux Therapeutics